Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
$437M |
| 2 |
AbbVie
ABBV
|
$380M |
| 3 |
Workday
WDAY
|
$366M |
| 4 |
Synopsys
SNPS
|
$323M |
| 5 |
Advanced Micro Devices
AMD
|
$286M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.71B |
| 2 |
Apple
AAPL
|
$984M |
| 3 |
Boston Scientific
BSX
|
$642M |
| 4 |
Microsoft
MSFT
|
$599M |
| 5 |
Texas Instruments
TXN
|
$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Bionano Genomics
BNGO
$18M
| $146K | ﹤0.01% |
56,615
+39
| +0.1% | +$101 |
|
2502
Senseonics Holdings
SENS
$369M
| $145K | ﹤0.01% |
74,132
+21
| +0% | +$41 |
|
|
SCPL
2503
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $145K | ﹤0.01% |
+11,222
| New | +$145K |
|
2504
Allogene Therapeutics
ALLO
$257M
| $143K | ﹤0.01% |
+15,647
| New | +$143K |
|
2505
Sangamo Therapeutics
SGMO
$164M
| $143K | ﹤0.01% |
24,721
+8
| +0% | +$46 |
|
2506
BridgeBio Pharma
BBIO
$9.99B
| $141K | ﹤0.01% |
13,848
-14
| -0.1% | -$143 |
|
2507
RPC Inc
RES
$1.05B
| $141K | ﹤0.01% |
13,167
+13
| +0.1% | +$139 |
|
2508
AEye
LIDR
$109M
| $140K | ﹤0.01% |
25,805
+3
| +0% | +$16 |
|
2509
Helix Energy Solutions
HLX
$963M
| $139K | ﹤0.01% |
29,073
+5
| +0% | +$24 |
|
2510
Accel Entertainment
ACEL
$957M
| $138K | ﹤0.01% |
11,374
+3
| +0% | +$36 |
|
|
AMRS
2511
DELISTED
Amyris Inc.
AMRS
| $138K | ﹤0.01% |
31,748
+38
| +0.1% | +$165 |
|
2512
Heritage Commerce
HTBK
$626M
| $137K | ﹤0.01% |
12,156
+2
| +0% | +$23 |
|
2513
Atara Biotherapeutics
ATRA
$84.2M
| $135K | ﹤0.01% |
+14,521
| New | +$135K |
|
2514
WisdomTree
WT
$1.98B
| $135K | ﹤0.01% |
22,877
+5
| +0% | +$30 |
|
2515
Hippo Holdings
HIPO
$833M
| $133K | ﹤0.01% |
67,140
-1,024
| -2% | -$2.03K |
|
|
CTEV
2516
Claritev Corporation
CTEV
$1.15B
| $133K | ﹤0.01% |
+28,557
| New | +$133K |
|
2517
OneSpaWorld
OSW
$2.28B
| $132K | ﹤0.01% |
12,976
| – | – |
|
2518
Invesco Mortgage Capital
IVR
$513M
| $131K | ﹤0.01% |
57,864
+149
| +0.3% | +$337 |
|
|
EGIO
2519
DELISTED
Edgio, Inc. Common Stock
EGIO
| $131K | ﹤0.01% |
25,228
+49
| +0.2% | +$254 |
|
|
ATRS
2520
DELISTED
Antares Pharma, Inc.
ATRS
| $131K | ﹤0.01% |
32,202
-117,730
| -79% | -$479K |
|
2521
Stagwell
STGW
$1.42B
| $130K | ﹤0.01% |
17,865
-1,048
| -6% | -$7.63K |
|
|
FFAI
2522
Faraday Future Intelligent Electric Inc. Common Stock
FFAI
$302M
| $130K | ﹤0.01% |
26,099
+12
| +0% | +$60 |
|
2523
Oscar Health
OSCR
$4.18B
| $129K | ﹤0.01% |
12,952
-365,545
| -97% | -$3.64M |
|
2524
Nuvation Bio
NUVB
$1.02B
| $127K | ﹤0.01% |
+24,218
| New | +$127K |
|
2525
Ocugen
OCGN
$319M
| $126K | ﹤0.01% |
+38,244
| New | +$126K |
|